MDWD

MediWound Ltd.

Healthcare Medicinal Chemicals & Botanical Products Market cap: $163.0M All insider activity → Quote and statistics → Sign in to watch MDWD Sign in to set a price alert

AI summary Cluster Open-Market Purchases by Directors Following Q1 2026 Results

Insider Score Band below 60

Research score: 42
AI adjustment: +9

Research score, not a recommendation.

Total bought$136.1K6 Form 4 purchases

Distinct insiders3open-market buyers

Lead insiderSHAMIR NACHUMDirector

Cluster window2026-05-29 → 2026-06-03active

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders

37%

Seniority executive rank of buyers (CEO/CFO/Director)

60%

Commitment purchase size relative to company & holdings

59%

Context buying into stock weakness signals conviction

85%

Timing coordinated purchases within a tight window

99%

Routine-purchase discount × 1.00

Company-type / offering discount × 1.00

Net insider selling penalty − 0

Why are they buying?

AI · discretionary · catalyst credible · documented

Directors likely timed their open-market purchases to follow the release of MediWound's first quarter 2026 financial results and corporate update on May 27, 2026.

Multiple directors (Samuel Rubinstein, David Morton Fox, and Nachum Shamir) bought shares on the open market between May 29 and June 3, 2026, shortly after the company reported Q1 2026 financial results and reaffirmed its full-year 2026 revenue guidance.

Filing references and sources

MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update (opens in a new tab)

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

6 Form 4 trades · 3 insiders Sign in to download CSV

Purchases in this cluster, grouped by insider, largest first
Date	Insider	Role	Shares	Price	Value	Filing
2026-06-03	SHAMIR NACHUM history of SHAMIR NACHUM's purchases	Director	6,000	$14.00 avg	$84.0K
2026-06-03	SHAMIR NACHUM		5,825	$14.00	$81.5K	SEC filing for SHAMIR NACHUM (opens in a new tab)
2026-06-03	SHAMIR NACHUM		175	$13.98	$2.4K	SEC filing for SHAMIR NACHUM (opens in a new tab)
2026-06-01	Fox David Morton history of Fox David Morton's purchases	Director	3,537	$14.11 avg	$49.9K
2026-06-01	Fox David Morton		1,797	$14.00	$25.2K	SEC filing for Fox David Morton (opens in a new tab)
2026-06-01	Fox David Morton		10	$14.23	$142	SEC filing for Fox David Morton (opens in a new tab)
2026-06-01	Fox David Morton		1,730	$14.23	$24.6K	SEC filing for Fox David Morton (opens in a new tab)
2026-05-29	Rubinstein Samuel history of Rubinstein Samuel's purchases	Director	150	$14.33	$2.1K	SEC filing for Rubinstein Samuel (opens in a new tab)
Total					$136.1K

What happened next

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days -0.1%63 days -10.7%126 days –